Who We Are | What We Do | Our Story
CGS works to strengthen inclusive, democratic governance of human biotechnologies. We are building a movement to bring social justice and human rights to the center of public and policy discussions about human genetics and assisted reproduction.
Confronting Eugenics to Build a Just Future works to equip scholars, students, advocates, and broader publics with tools to recognize and challenge the resurgence and normalization of eugenics, especially in US science, medicine, and technology. CGS has established a core network of publicly engaged scholars and social justice advocates to deepen relationships, identify eugenic narratives, and explore opportunities for anti-eugenic interventions.
CGS is convening a small group of advocacy leaders to position assisted reproductive and genetic technologies within larger fights for reproductive justice, disability rights, and LGBTQ+ rights, and health equity. The project aims to provide opportunities for social justice advocates and scholars across sectors to align key strategies and promote intersectional messaging on these technologies, and to clarify approaches that challenge eugenics and promote equity and justice.
The Missing Voices Initiative calls for broad societal inclusion in discussions of heritable genome editing. MVI models robust and inclusive engagement by bringing together civil society advocates and socially engaged scholars to amplify social justice and human rights voices and perspectives in debates about heritable genome editing.
The CGS blog, Biopolitical Times, publishes timely posts on eugenics, assisted reproduction, heritable genome editing, gene therapy, and more, written by CGS staff and guest contributors. Our monthly newsletter, Biopolitical News & Views, features CGS-authored commentary, organizational updates, and a curated collection of news articles on human genetic and reproductive technologies. Subscribe today and catch up on past issues.
CGS speaks and writes widely. Our staff are quoted frequently in the media and our research is cited often. We regularly comment on biotech developments through press statements, op-eds, and commentaries. We frequently speak and participate in policy discussions on human biotechnologies.
A comprehensive and non-commercial resource about the complexities of cross-border surrogacy, the Surrogacy360 site offers policy maps, curated news, and resources that keep intended parents, advocates, and scholars up to date on ever-changing surrogacy regulations and policy debates.
CGS organizes in-person and virtual events that bring social justice and human rights perspectives to wide-ranging topics in human genetic and reproductive technologies. You can find recordings in our video library and on our YouTube page. The video library also includes talks and media appearances by CGS staff, fellows, and consultants.
